Formulation and characterization of Gastroretentive drug delivery system
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
newlineGastroretentive drug delivery system (GRDDS) is among the novel approaches in the
newlineoral sustained release dosage forms. Drugs which have short biological half-life and are
newlinesimply absorbed through GIT often require frequent dosing to attain therapeutic activity
newlinebecause of quick elimination from body. This limitation can be overcome by developing
newlineoral sustained release GRDDS. It maintains therapeutic concentration over an extended
newlineduration by releasing drug slowly in GIT. Post oral administration GRDDS is retained
newlinein gastric region and release drug in sustained fashion. Because of inferior absorption of
newlinenumerous API in the lower part of GIT, it is required that controlled release DDS to be
newlinepositioned in upper part of GIT. These DDS bear two diversities: short retention time of
newlineDDS in stomach and small stomach emptying time which may result in incomplete
newlinerelease in absorption window resulting in reduced efficacy.
newlineIn present work Gastroretentive drug delivery system of captopril and simvastatin is
newlineprepared by amalgamating novel drug delivery technologies like chitosan microparticles
newlineand SMEDDS with gastroretentive delivery system
newlineCaptopril is an angiotensin converting enzyme inhibitor, usually prescribed in
newlinetreatment of hypertension and require long term use for its therapeutic benefit. It
newlinebelongs to BCS class III i.e. high solubility and low permeability. So once a daily
newlinecaptopril oral formulation would be significant in reducing the fluctuations in blood
newlineconcentration and increasing patient compliance. Chitosan microparticles were
newlinedeveloped with aim to improve the permeability and it was further incorporated in the
newlinegastroretentive floating mini tablets. Chitosan microparticles were systemically
newlinedeveloped by applying Plackett Burman design for screening different formulation
newlinefactors. Total 11 factors were screened at two levels considering % entrapment
newlineefficiency as the response. Chitosan concentration, TPP concentration and speed of
newlinestirring were the significant factors out of total 11 factors screened.